BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4104981)

  • 1. Role of soluble lymphocyte mediators in malignant-tumour destruction.
    Mackler BF
    Lancet; 1971 Aug; 2(7719):297-301. PubMed ID: 4104981
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological facilitation, a broadening of the concept of the enhancement phenomenon.
    Voisin GA
    Prog Allergy; 1971; 15():328-485. PubMed ID: 4151281
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological enhancement: a study of blocking antibodies.
    Feldman JD
    Adv Immunol; 1972; 15():167-214. PubMed ID: 4404339
    [No Abstract]   [Full Text] [Related]  

  • 4. Host responses to malignant disease.
    Cochran AJ
    Br J Dermatol; 1970 Jul; 83(1):208-12. PubMed ID: 4393811
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunity.
    Valentine FT; Lawrence HS
    Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble mouse histocompatibility antigens.
    Koene R; McKenzie IF; Painter E; Sachs DH; Winn HJ; Russell PS
    Transplant Proc; 1971 Mar; 3(1):231-3. PubMed ID: 4106314
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cell-based immunology in the delayed hypersensitivity phenomena].
    Del Rey Calero J
    Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1383-425. PubMed ID: 5525224
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocytes in immunobiology.
    Gotoff SP
    Adv Pediatr; 1970; 17():139-83. PubMed ID: 4394438
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological effects of heterologous antilymphocyte serum.
    Taub TN
    Prog Allergy; 1970; 14():208-58. PubMed ID: 4404047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basic and clinical significance of lymphokines with special reference to migration inhibitory factor].
    Acki T; Niinaka T
    Nihon Rinsho; 1972 Feb; 30(2):615-28. PubMed ID: 4552559
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immune responses. Report of a WHO scientific group.
    World Health Organ Tech Rep Ser; 1969; 423():1-61. PubMed ID: 4391291
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive enzymes.
    Hersh EM
    Transplant Proc; 1973 Sep; 5(3):1211-4. PubMed ID: 4147027
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte receptors for antigen.
    Marchalonis JJ
    J Med; 1974; 5(6):329-67. PubMed ID: 4153398
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immunity: mechanisms, significance, and evaluation.
    Papageorgiou PS
    Pediatr Ann; 1976 Jun; 5(6):378-96. PubMed ID: 5697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer factor in delayed hypersensitivity.
    Lawrence HS; Valentine FT
    Ann N Y Acad Sci; 1970 Feb; 169(1):269-87. PubMed ID: 5263843
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limitations of the nonimmune lymphocyte transfer test as a method of selecting donors for transplantation (a review of the literature)].
    Shereshkov SI
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):47-52. PubMed ID: 4150019
    [No Abstract]   [Full Text] [Related]  

  • 18. The antigenic stimulus in human transplantation.
    Kahan BD; Mittal KK; Reisfeld RA; Terasaki PI; Bergan JJ
    Surgery; 1973 Jul; 74(1):153-62. PubMed ID: 4146045
    [No Abstract]   [Full Text] [Related]  

  • 19. [Migration inhibition test in clinical diagnostics].
    Górski A
    Pol Arch Med Wewn; 1972; 48(1):83-90. PubMed ID: 4551131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transplantation and tumor immunology].
    Schneeweiss U
    Dtsch Gesundheitsw; 1969 Oct; 24(42):1969-75 contd. PubMed ID: 4394121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.